Skip to content


Veltassa (patiromer) is a small molecule pharmaceutical. Patiromer was first approved as Veltassa on 2015-10-21. It is used to treat hyperkalemia in the USA. It has been approved in Europe to treat hyperkalemia. Veltassa's patents are valid until 2033-10-08 (FDA).
Trade Name Veltassa
Common Name Patiromer
Indication hyperkalemia
Drug Class Polymers
Get full access now